This report provides a detailed description of vaccine delivery devices and the latest technologies in the market. The report includes market estimates for different types of vaccine delivery devices. The report also includes recent technological developments and assessments of product performance in the market.
Based on the device type, the vaccine delivery device market is segmented into syringes, jet injectors and other novel technologies (e.g., microneedle patches, electroporation-based needle-free injection system, nasal spray, etc.).
Based on the route of administration, the vaccine delivery device market is segmented into intramuscular injection, subcutaneous injection and other routes of administration (intradermal, oral route, etc.).
Based on end-users, the vaccine delivery device market is segmented into hospitals, clinics and other end-users (vaccination centers, tertiary care centers, etc.).
The report includes a list of pipeline products available in the market. The report discusses the qualitative and quantitative factors influencing the market growth, as well as market drivers, restraints and opportunities.
This report also discusses competition in the global vaccine delivery device market and the key players’ strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also emphasizes the company profiles of major vendors including company overview, key product offerings, financial statistics and recent developments. The report provides insights on the market share and upcoming regional demand for vaccine delivery devices.
Some of the major market players discussed in the report are BD, ApiJect Systems Corp., Hindustan Syringes & Medical Devices Ltd., Terumo Corp. and Smiths Medical. For market estimates, data has been provided for the year 2019 as the base year, with forecasts for 2021 through 2026. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Report Includes
- 55 tables
- An overview of the global markets for vaccine delivery systems
- Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast and technological advancements and strategic innovations within the industry
- Highlights of the market potential for vaccine delivery systems by type of device, route of administration, end user, and region
- Discussion on vaccines limitations like inefficient activation of a cell-mediated immune response and the deficiency of protective mucosal immunity, and information on gene-based vaccines like DNA & m-RNA vaccines
ALSO READ : http://www.marketwatch.com/story/natural-astaxanthin-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2020-2027-2021-07-06
- Coverage of recent developments which have been focused on intradermal vaccine formulations for vaccine delivery devices to activate both a systemic and mucosal immune response
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Profile descriptions of the leading industry players including ApiJect Systems Corp., Corium Inc., Enesi Pharma, Hindustan Syringes & Medical Devices Ltd., PharmaJet, SCHOTT, and Vaxxas6
Table of Contents
Chapter 1 Introduction
Study Background
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Vaccines and Immunization: Overview
Types of Vaccines
Attenuated (Live) Vaccines
Inactivated (Killed) Vaccines
Toxoid Vaccines
Subunit Vaccines
Conjugate Vaccines
Recombinant Vector Vaccines
DNA Vaccines
RNA Vaccines
Immunization
Types of Vaccine Delivery Devices
Syringes
Jet Injectors
Microarray Patches (Microneedle Patches)
Electroporation-Based Needle-Free Injections
Nasal Spray
Route of Administration
Injectable Route
Intramuscular Injections
Subcutaneous Injections
Intradermal Injections
Oral Route
Intranasal Route
Regulatory Aspects: Vaccine Recommendations and Guidelines of the ACIP
Safe Use of Needles and Syringes
Regulatory Pathways for Jet Injectors
Regulatory Pathways for Microarray Patches
Chapter 4 Impact of COVID-19 Pandemic
Impact of COVID-19 on Vaccine Supplies
Formation of COVAX
COVAX Facility
ALSO READ : http://www.marketwatch.com/story/endoscopic-submucosal-dissection-tool-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2021-2028-2021-07-07
Need for COVAX
Impact of COVID-19 on Routine Immunization
Impact of COVID-19 on Syringe Supplies
Shortage of Low Dead-Space Specialty Syringes
South Korean Company to Double Syringe Supplies for a COVID-19 Vaccine Campaign
Optimistic Impact of COVD-19 on Syringe Manufacturers
Chapter 5 Vaccine Delivery Device Market Dynamics
Market Drivers
Growing Awareness of Immunization Across the Globe
Growing Investments and Support in R&D for New Vaccines
Rising Technological and Manufacturing Advancements in Vaccine Delivery Devices
Growing Incidence of Pandemic Outbreaks
Growing Cases of Needle Phobia
Market Restraints
Comparative High Cost of Needle-Free Technology, especially in Emerging Countries
Stringent Government Regulations
Market Opportunities
Opportunities in Emerging Nations
Competitive Landscape
Chapter 6 Market Breakdown by Device
Global Vaccine Delivery Device Market by Device Type
Syringes
Market Size and Forecast
Jet Injectors
Market Size and Forecast
Others
Market Size and Forecast
Chapter 7 Market Breakdown by Route of Administration
Global Vaccine Delivery Devices Market by Route of Administration
Intramuscular Injection
Market Size and Forecast
Subcutaneous Injection
Market Size and Forecast
Others
Market Size and Forecast
Chapter 8 Market Breakdown by End User
Global Vaccine Delivery Devices Market by End User
Hospitals
Market Size and Forecast
Clinics
Market Size and Forecast
Others
Market Size and Forecast
Chapter 9 Market Breakdown by Region
Global Market for Vaccine Delivery Devices by Region
North America
United States
Canada
Europe
Russia
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
India
China
Japan
Indonesia
Rest of Asia-Pacific
Rest of World
Market Size and Forecast
Chapter 10 Market Breakdown by Type of Vaccine Technology
Global Vaccine Delivery Device Market by Type of Vaccine Technology
Conjugate Vaccines
Inactivated Vaccines
Attenuated (Live) Vaccines
DNA/rDNA Vaccines
Subunit Vaccines
Toxoid Vaccines
Other/Combination Vaccines
Chapter 11 Industry Events
Market Strategies
Key Mergers and Acquisitions
Companies
Key Product and Technology Developments
Companies
Chapter 12 Key Pipeline Products
Key Pipeline Products
MicroCor
The ImplaVax Technology
TriGrid Delivery System
Kindeva Drug Delivery
VAXXAS Pty Ltd.
....continued
CONTACT DETAILS
+44 203 500 2763
+1 62 825 80070
971 0503084105
Market SynopsisMarket Research Future (MRFR) postulates that the biosimilars market is predicted to garner USD 3.35 billion, grabbing a CAGR of 26% throughout the forecast period (2017-2023).
They are generally derived from a plant, bacteria, yeast, and other several processes.
They are produced by two main processes, recombinant DNA technology and controlled gene expression.Market Potential and PitfallsWith the augmenting incidences of several chronic diseases, growing demand for cheap medical products, and strategic collaborations leading to clinical trials and enhanced productivity, the global biosimilars market is estimated to flourish throughout the appraisal period.
Biosimilars are extensively used in the treatment and prevention of chronic diseases like cancer, diabetes, autoimmune disease, cardiovascular diseases (CVDs), kidney failure, rheumatoid arthritis, hematological disease, hormone growth deficiency, and infectious disease.
Moreover, different private and government bodies are promoting the use of biosimilars over synthetic drugs and conventional biologics, which is further propelling the growth of the market across the globe.
Also, with the rapid growth in the pharmaceutical sector combined with the high cost of existing biological drugs, the market is anticipated to boom.
The Global Ampicillin Trihydrate Market Research Report 2020-2026 gives a point by point analysis rely upon the far expansive exploration, especially on questions with respect to industry size, improvement situations, potential players, designs, and focused analysis with forecast.
Ampicillin Trihydrate market is a expert and inside and out study on the present state which centers on the major drivers and restraints for the key players.
The research report gives a total evaluation of the competitive environment, including firm profiling of driving players encouraging in the Ampicillin Trihydrate industry.
The report on the Ampicillin Trihydrate research offers efficiently produced statistics observing a comparison of the essential gauges over the whole forecast session.The Ampicillin Trihydrate report is an expert analysis that furnishes exhaustive information relating to the Ampicillin Trihydrate market which proposes types, applications, industry chain layout policies in addition to plans, product specifications, manufacturing processes, and revenue structures, among others.
The portrayal, comprehensive SWOT analysis and seller analysis is given with estimate.Detailed TOC along with also Charts & Tables of Ampicillin Trihydrate Market Research Report accessible at: https://www.futuristicreports.com/request-sample/64520Top Important Players:BayerBristol-Myers Squibb CompanyKopran LimitedICC ChemicalDolphin PharmaceuticalsShaanxi Top-PharmchemThis Ampicillin Trihydrate report explores feasibility with an objective of educational new entrants in regards to the changes within the market.
The description, thorough SWOT analysis & investment analysis is given which Ampicillin Trihydrate predictions are impending opportunities for its players.Global Ampicillin Trihydrate Market is abbreviated as Follows-By Types:Intramuscular InjectionIntravenous InjectionBy Applications:AdultsChildrenNewbornGeographically, global Ampicillin Trihydrate market report offers segment research and export and import status, require status, production volume, including regions such as North America, South America, Europe, China, Japan, India, The Middle East & Africa, Others.Regional Or Country Level Customization : https://www.futuristicreports.com/customize-request/64520The Ampicillin Trihydrate market gives fundamental data about the significant difficulties that will impact on development.
Ageing demographics, rapid technological developments, increasing adoption of home infusion therapies, favourable government policies and regulations are are key factors contributing to high CAGR of Home infusion therapy during forecast period.Market Size – USD 22.03 Billion in 2018, Market Growth - CAGR of 7.2%, Market Trends – Product launches and research for advanced Home infusion therapyAccording to current analysis of Reports and Data, the global Home Infusion Therapy Market was valued at USD 22.03 billion in 2018 and is expected to reach USD 38.41 billion by the year 2026, at a CAGR of 7.2%.
The advantage infusion offers is that it helps deliver a precise dose of the drug quickly and efficiently, and in a well-controlled manner throughout the body.
It is also used for irritating solutions; those can cause pain and even damage tissues if administered by subcutaneous or intramuscular injection.Moving care into the home is a very important step of change in healthcare.
Home infusion drugs are often not readily available through standard pharmacies and comparatively higher in cost.
However, increasing risk with patient's safety and occurrence of mistakes while using infusion devices and issues related to reimbursement policies for home infusion therapy are the major hindrance for market growth during the forecast period.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2250The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply & demand patterns.
It also sheds light on recent technological developments, product advancements, and research and development activities in the region.The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies.
Biosimilars Market SynopsisMarket Research Future (MRFR) postulates that the global biosimilars market is predicted to garner USD 3.35 billion, grabbing a CAGR of 26% throughout the forecast period (2017-2023).
They are produced by two main processes, recombinant DNA technology and controlled gene expression.Biosimilars Market Potential and PitfallsWith the augmenting incidences of several chronic diseases, growing demand for cheap medical products, and strategic collaborations leading to clinical trials and enhanced productivity, the global biosimilars market is estimated to flourish throughout the appraisal period.
Also, with the rapid growth in the pharmaceutical sector combined with the high cost of existing biological drugs, the market is anticipated to boom.On the contrary, physician skepticism coupled with the lack of awareness regarding biosimilars is some of the top barriers likely to vitiate the market growth in the coming years.
Despite such hiccups, discounted prices of biosimilars will impact the overall biosimilar sales, as patients are the key beneficiaries.Global Biosimilars Market: Segmental AnalysisThe global biosimilars market has been segmented on the basis of product, application, and manufacturing.By mode of product, the global biosimilars market has been segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and others.
The growth is credited to the wide therapeutic area of such proteins coupled with the presence biosimilar version of monoclonal antibodies at much lower rates.By mode of application, the global biosimilars market has been segmented into oncology, immune diseases, blood-related disorders, and others.By mode of manufacturing, the global biosimilars market has been segmented into contract manufacturing and in-house manufacturing.
The growth in the regional market is likely to be stimulated by patent expiry of biologic products combined with the launch of new biosimilars and the advent of new market participants.The North American region is predicted to occupy the second largest share in the global market owing to technological advancements and extensive medical research.
The Global Sumatriptan Succinate Market Report 2025 is intended to provide a complete overview of various market metrics.
This report is developed by a team of professional authors and scholars.
The data contained in the report is collected through a very accurate methodology.
Recent research data has helped professionals respond to growth.Key Player Mentioned: GlaxoSmithKline , Imitrex , Teva , Sandoz , Mylan , Roxane Pa , Dabur Pharmaceuticals , Sun Pharmaceutical, Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.
We provided important information points, including expansion, sale, new product launches, partnerships, mergers, acquisitions and other strategic initiatives.
It also helps in determining reasons for the progress of certain segments over others within the future years.
